Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- New AACC Guidance Advises Cervical Cancer Testing Strategies for Clinicians and Labs March 10, 2023
- The First Step in Market-Sizing the Molecular Point of Care Market: Defining What it is. March 9, 2023
- Brazil and Mexico Lead IVD Investments in Latin America March 7, 2023
- Still Room to Grow in Infectious Disease IVD March 3, 2023
- China: Molecular Point-of-Care’s International Market to Watch February 21, 2023
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
COVID-19 Test Market: $33BN in Revenues in 2021, Future Still a Guess
Kalorama has just completed a report on the COVID-19 in vitro diagnostic testing market. 2021 was a year in which point-of-care antigen tests, lab-based PCR tests, rapid PCR and even home tests were available to the market. Also antibody tests, NGS tests and other tests were brought to bear in diagnosing cases. The scourge of […]
Point-of-Care (POC) Diagnostic Testing: 5 Key Trends to Watch from 2022-2026
Globally, millions of dollars are spent annually on point-of-care (POC) diagnostic testing, both professional testing (which includes physician office labs, clinic labs, employer labs and hospital labs) and self-testing (which includes home, drug store testing and continuous glucose testing). In 2021, amidst the pandemic, the POC market reached $41,149 million ($41.1 billion) and the market […]
At-Home Diagnostic Testing: COVID-19 Has Consumers More Comfortable with Tests for Infectious Diseases
The global at-home in vitro diagnostics (IVD) testing market had sales of $20.5 billion in 2021, up more than 35% from the previous year, largely due to increased testing in the infectious disease segment. Glucose testing and COVID-19 testing accounted for the majority of sales, according to leading medical market researcher Kalorama Information in the […]
12 Recent Developments in Cell and Gene Therapy as of April 22, 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. In public offering news, Massachusetts-based Selecta Biosciences has announced a $38.7 million public offering to continue developing ImmTOR, its antigen-specific immune tolerance platform. Leading the private financing news, Cambridge-based cell […]
106 Billion IVD Procedures and Counting
“Medical market researcher Kalorama Information forecasts exponential growth in both in vitro diagnostics (IVD) procedures and sales between 2021 and 2026.” The global in vitro diagnostics (IVD) procedures market continues to grow off momentum originating at the height of the pandemic and lingering on today. There are currently 106,624 million (106 billion) in vitro […]
Infectious Disease Testing Expected to Grow Beyond COVID-19
While COVID-19 has made the need for in vitro diagnostics (IVD) that can detect infectious diseases front and center, demand for these tests was building before the pandemic and revenues for test products will grow says a report from a major publisher of IVD market research. The industry consists of tests and related products […]
COVID-19 and 6 Other Trends Impacting the In Vitro Diagnostics (IVD) Market
“In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information Make no mistake, the in vitro diagnostics (IVD) […]
13 Recent Developments in Cell and Gene Therapy as of April 8, 2022
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Bristol Myers Squibb, based in New York, NY, has announced that the European Commission (EC) has granted Marketing Authorization for Breyanzi (lisocabtagene maraleucel; liso-cel), its CD19-targeted chimeric antigen receptor (CAR)-T […]
Pets are Key to $3.5 Billion Veterinary Diagnostic Testing Market
“Companion animals (including dogs, cats, and horses) account for 70% of overall market, finds new report by Kalorama Information” – Kalorama Information In the global veterinary diagnostic testing market, the companion animal segment (pets and domestic animals including horses) comprises almost 70% of the $3,540 million ($3.5 billion) overall market, with the food animal segment […]
Molecular Point of Care Market Reaches 3.5 Billion
The molecular point of care market reached 3,555 million in 2021, according to Kalorama Information’s latest report. The Market and Potential for Molecular Point-of-Care. COVID-19 sales were the main driver. That is 10x growth in revenues from 2019. The COVID-19 pandemic and consistent arrival of variants are the determining factor, and the continued presence of […]